Why COVID-19 trials should be blinded (as any other one)
DOI:
https://doi.org/10.17267/2675-021Xevidence.v2i1.2841Keywords:
Blinding. Clinical trials. COVID-19.Downloads
Download data is not yet available.
Downloads
Published
04/01/2020
Issue
Section
Concept Articles
License
The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.
![Creative Commons License](https://i.creativecommons.org/l/by/4.0/80x15.png)
How to Cite
1.
Pacheco RL, Martimbianco ALC, Latorraca C de OC, Riera R. Why COVID-19 trials should be blinded (as any other one). Evidence [Internet]. 2020 Apr. 1 [cited 2024 Aug. 24];2(1):25-7. Available from: https://www5.bahiana.edu.br/index.php/evidence/article/view/2841